Literature DB >> 32544234

Reply to Dudoignon et al.

Timothy M Rawson1,2,3, Luke S P Moore1,4,5, Nina Zhu1, Nishanthy Ranganathan3,4, Keira Skolimowska3,4, Mark Gilchrist3,4, Giovanni Satta3,4, Graham Cooke3,4, Alison Holmes1,2,3,4.   

Abstract

Year:  2021        PMID： 32544234     DOI： 10.1093/cid/ciaa767

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  4 in total

1.  Antimicrobial multidrug resistance in the era of COVID-19: a forgotten plight?

Authors:  Eric Pelfrene; Radu Botgros; Marco Cavaleri
Journal:  Antimicrob Resist Infect Control       Date:  2021-01-29       Impact factor: 4.887

2.  Effects of coronavirus disease 2019 (COVID-19) pandemic on antimicrobial prevalence and prescribing in a tertiary hospital in Singapore.

Authors:  Tat Ming Ng; Sock Hoon Tan; Shi Thong Heng; Hui Lin Tay; Min Yi Yap; Boon Hou Chua; Christine B Teng; David C Lye; Tau Hong Lee
Journal:  Antimicrob Resist Infect Control       Date:  2021-02-03       Impact factor: 4.887

3.  Antimicrobial use, drug-resistant infections and COVID-19.

Authors:  Timothy M Rawson; Damien Ming; Raheelah Ahmad; Luke S P Moore; Alison H Holmes
Journal:  Nat Rev Microbiol       Date:  2020-08       Impact factor: 60.633

4.  Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome.

Authors:  Tommaso Bardi; Vicente Pintado; Maria Gomez-Rojo; Rosa Escudero-Sanchez; Amal Azzam Lopez; Yolanda Diez-Remesal; Nilda Martinez Castro; Patricia Ruiz-Garbajosa; David Pestaña
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-03       Impact factor: 3.267
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.